Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samantha Lane
Observed names:
Lane, Samantha,
S Lane,
S. Lane
Institutions:
Drug Safety Research Unit,
University of Portsmouth
Observed institutions:
Rosalind Franklin University of Medicine and Science,
Drug Safety Research Unit,
University of Portsmouth
ORCID:
0000-0001-7532-1149
Observed ORCID:
0000-0001-7532-1149
OpenAlex ID:
A5086527607
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
2022
·
Samantha Lane
, Alison Yeomans
, et al.
·
BMJ Open
·
71
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
2020
·
Vicki Osborne
, Miranda Davies
, et al.
·
Drug Safety
·
69
PDF
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
2020
·
Miranda Davies
, Vicki Osborne
, et al.
·
Drug Safety
·
68
PDF
The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism
2015
·
Steven McRae
, Jawed Iqbal
, et al.
·
Journal of Biological Chemistry
·
59
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance
2025
·
Salvatore Crisafulli
, Andrew Bate
, et al.
·
Drug Safety
·
45
PDF
Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine
2022
·
Raquel Herrera-Comoglio
, Samantha Lane
·
New England Journal of Medicine
·
45
PDF
Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012
2018
·
Samantha Lane
, Elizabeth Lynn
, et al.
·
BMJ Open
·
28
PDF
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
2022
·
Samantha Lane
, Alison Yeomans
, et al.
·
BMJ Open
·
16
PDF
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
2020
·
Saad Shakir
, Samantha Lane
, et al.
·
Drug Safety
·
15
PDF
Assessing Case Fatality and the Effect of Treatment on Cases of Thrombosis With Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca in the United Kingdom
2021
·
Samantha Lane
, Saad Shakir
·
Drug Safety
·
13
PDF
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance
2024
·
Dawn Cooper
, Robert W. Platt
, et al.
·
Clinical Therapeutics
·
10
PDF
A Review of its Pharmacological Properties and Clinical Efficacy in the Treatment of Allergic Disorders
1996
·
E. Almeda
, Kalliopi Kontou-Fili
, et al.
·
9
A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
2024
·
Alison Evans
, Debabrata Roy
, et al.
·
Frontiers in Pharmacology
·
5
Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study
2025
·
Alison Evans
, Debabrata Roy
, et al.
·
BMJ Open
·
4
Withdrawal: The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism.
2018
·
Steven McRae
, Jawed Iqbal
, et al.
·
Journal of Biological Chemistry
·
4
PDF
From a pyramid to an amphitheatre (triangle to circle): embracing the totality of evidence for the postmarketing evaluation of the safety of therapeutic interventions
2025
·
Saad Shakir
, Samantha Lane
·
BMJ Open
·
3
PDF
Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action
2024
·
Samantha Lane
, Elizabeth Lynn
, et al.
·
Pharmacoepidemiology and Drug Safety
·
2
PDF
Convalescent Plasma in treatment of COVID-19: A review of evidence for a living systematic benefit-risk assessment
2020
·
Miranda Davies
, Samantha Lane
, et al.
·
medRxiv
·
2
PDF
P20: Understanding the impact of a cure for hepatitis C from the patient perspective
2013
·
S Lane
, S Cline
, et al.
·
Journal of Viral Hepatitis
·
2
PDF
Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study
2026
·
Joan Forns
, Romin Pajouheshnia
, et al.
·
Vaccine
·
1
Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group
2026
·
Florence van Hunsel
, Samantha Lane
, et al.
·
Drug Safety
·
1
PDF
A concept for causality assessment and causal inference of adverse events cases
2022
·
Ahmed Al-Imam
, Ahmed Sami
, et al.
·
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
·
1
PDF
The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology
2021
·
Vicki Osborne
, Samantha Lane
, et al.
·
Drug Safety
·
1
PDF
Trade Mark Legislation and the Pharmaceutical Industry
1999
·
Samantha Lane
, J. C. Phillips
·
Monographs
·
1
TARGET-EU: Effectiveness of BNT162b2 mRNA COVID-19 vaccine in healthy individuals or with stable pre-existing medical conditions against SARS-CoV-2 infection
2026
·
Andaur Navarro, Constanza L.
, Mohammadi, Sima
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
40
Citation count:
475
H-index:
10
I10-index:
11
Year
Topic
Type
